-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Immunocore Holdings plc quarterly/annual Revenues history and growth rate from 2021 to 2023.
- Immunocore Holdings plc Revenues for the quarter ending June 30, 2024 was $75.4M, a 26.2% increase year-over-year.
- Immunocore Holdings plc annual Revenues for 2023 was $249M, a 43.1% increase from 2022.
- Immunocore Holdings plc annual Revenues for 2022 was $174M, a 378% increase from 2021.